Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
VRC01广谱中和抗体在接受急性治疗的HIV感染成人患者中的安全性和有效性(RV397):一项II期随机、双盲、安慰剂对照试验
期刊:Lancet HIV
影响因子:13
doi:10.1016/S2352-3018(19)30053-0
Crowell, Trevor A; Colby, Donn J; Pinyakorn, Suteeraporn; Sacdalan, Carlo; Pagliuzza, Amélie; Intasan, Jintana; Benjapornpong, Khunthalee; Tangnaree, Kamonkan; Chomchey, Nitiya; Kroon, Eugène; de Souza, Mark S; Tovanabutra, Sodsai; Rolland, Morgane; Eller, Michael A; Paquin-Proulx, Dominic; Bolton, Diane L; Tokarev, Andrey; Thomas, Rasmi; Takata, Hiroshi; Trautmann, Lydie; Krebs, Shelly J; Modjarrad, Kayvon; McDermott, Adrian B; Bailer, Robert T; Doria-Rose, Nicole; Patel, Bijal; Gorelick, Robert J; Fullmer, Brandie A; Schuetz, Alexandra; Grandin, Pornsuk V; O'Connell, Robert J; Ledgerwood, Julie E; Graham, Barney S; Tressler, Randall; Mascola, John R; Chomont, Nicolas; Michael, Nelson L; Robb, Merlin L; Phanuphak, Nittaya; Ananworanich, Jintanat